Pyrazole, Isoxazoline and Bypyrimidine Derivatives from Polygonum senegalense and Psiadia punctulata Flavonoids and their Anti-Microbial Activities


Pharmacognosy Communications,2017,7,1,47-52.
Published:October 2016
Type:Original Article

Pyrazole, Isoxazoline and Bypyrimidine Derivatives from Polygonum senegalense and Psiadia punctulata Flavonoids and their Anti-Microbial Activities

Evans Okemwa Kenandaa, Leonidah Kerubo Omosab
aDepartment of Chemistry, School of Pure and Applied Sciences, Kisii University, P.O. Box 408-40200 Kisii, Kenya
bDepartment of Chemistry, School of Physical Sciences, University of Nairobi, P.O. Box 30197-00100 Nairobi, Kenya


Currently, researchers have given special attention to the synthesis of heterocyclic compounds with nitrogen and oxygen five in five- or six-membered ring systems. This is mainly due to their wide range of biological activities. Hence, in this study, isoxazoline, pyrazole and bypyrimidine derivatives were synthesized from flavonoids, previously isolated from Polygonum senegalense and Psiadia panctulata, and assessed for their anti-fungal activity. A flavone was reacted with hydrazine hydrate to afford a pyrazole analogue 5-methoxy-2-(5-(2,3,4,5-tetramethoxyphenyl)-1H-pyrazol-3-yl)benzene-1,3- diol (1) Two isoxazoline derivatives namely, 2-(4,5-dihydro-5-phenylisoxazol- 3-yl)-5-methoxybenzene-1,3-diol (2) and 2-(-4,5-dihydro-5-phenylisoxazol- 3-yl)-3,5-dimethoxyphenol (3) were successfully synthesized by the reaction of chalcones with hydroxylamine hydrochloride. An oxime derivative (4) was also generated from a similar procedure. A reaction between a chalcone and thiourea gave a bypyrimidine derivative, 4,5-dihydro-6-(2,4- dihydroxy-3,6-dimethoxyphenyl)-4-phenylpyrimidine-2-(1H)-thione (5). The products were then assessed for their anti-bacterial and anti-fungal activity. All compounds showed no significant activity except compound 2 that demonstrated activity against standard anti-bacterial agent, Streptococcus aureus with IC50 value of 7.56 and anti-fungal Candida neoformans, Candida krusei and Candida glabrata strains with IC50 values 8.01, 8.11 and 13.74 μg/mL respectively. We, therefore, recommend synthetic optimization of compound 2 as a potential anti-microbial agent.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.